A serine-threonine phosphatase 2A (PP2A), responsible for dephosphorylation of many key cell regulators, has been identified as one of the factors in CML advancement to BP. The gene discussed is PTPA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.